Vamsidhar Velcheti, MD
Clinician and researcher Vamsidhar ‘Vamsi’ Velcheti, MD, recently joined the Perlmutter Cancer Center at New York University (NYU) Langone Health as Director of Thoracic Medical Oncology. He aims to improve clinical care, increase translational and clinical research, and promote interdisciplinary collaborations in lung cancer. Prior to joining the Perlmutter Cancer Center, Dr. Velcheti was Associate Director of the Center of Immuno-Oncology Research at Cleveland Clinic’s Taussig Cancer Institute.
Dr. Velcheti brings his experience with biomarkers to NYU Langone, which will broaden the depth and breadth of clinical trials for patients with lung cancer at the Perlmutter Cancer Center. He also serves as a principal investigator of a multisite, National Institutes of Health–funded translational research project on early-stage lung cancer. Dr. Velcheti will be a major contributor to Perlmutter Cancer Center’s Lung Cancer Center—a multidisciplinary initiative to bring new research discoveries to patients more quickly and expand clinical collaborations.
“It is an honor to join a fantastic institution like Perlmutter Cancer Center,” said Dr. Velcheti. “Lung cancer is a highly complex disease for which most patients require a team approach. With our world-class faculty and facilities, there is immense potential for Perlmutter Cancer Center to be one of the premier centers of excellence in lung cancer.” ■
